Fig. 3From: Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiencyMelt curve of synthetic Cel-miR-39-1 (A) and synthetic miRNA-16 (B). Melting curve analysis was performed from 60 to 95 °C for Cel-miRNA-39-1 and from 65 to 95 °C for miRNA-16Back to article page